Altered signaling pathway due to the chromosomal rearrangement event of PML–RARA fusion [11] is often observed only in acute promyelocytic leukemia (APL), a distinct subgroup of acute myeloid leukemia (AML). The gene discussed is RARA; the disease is acute myeloid leukemia.